BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9819015)

  • 1. Changes in cardiac diastolic dimensions precede hypertrophy in early stages of hypertension.
    Lemme C; Lindvall K; de Faire U
    J Hum Hypertens; 1998 Oct; 12(10):679-83. PubMed ID: 9819015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left ventricular diastolic dysfunction in essential hypertension.
    Avdić S; Mujcinović Z; Asćerić M; Nukić S; Kusljugić Z; Smajić E; Arapcić S
    Bosn J Basic Med Sci; 2007 Feb; 7(1):15-20. PubMed ID: 17489762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left atrial myocardial function in either physiological or pathological left ventricular hypertrophy: a two-dimensional speckle strain study.
    D'Andrea A; De Corato G; Scarafile R; Romano S; Reigler L; Mita C; Allocca F; Limongelli G; Gigantino G; Liccardo B; Cuomo S; Tagliamonte G; Caso P; Calbrò R
    Br J Sports Med; 2008 Aug; 42(8):696-702. PubMed ID: 18070810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural cardiac changes in relation to 24-h ambulatory blood pressure levels in borderline hypertension.
    Lemne C; Lindvall K; Georgiades A; Fredrikson M; de Faire U
    J Intern Med; 1995 Jul; 238(1):49-57. PubMed ID: 7608646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlations between blood pressure, left ventricular hypertrophy, and left ventricular diastolic function in hypertensive patients].
    Ito O; Okamoto M; Murakami Y; Nakayama R
    J Cardiol; 1991; 21(4):931-41. PubMed ID: 1844449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of left ventricular hypertrophy on the diastolic performance in hypertensive patients and in athletes.
    Lefkos N; Boudonas G; Vassilicos V; Efthymiadis A
    Acta Cardiol; 1993; 48(5):507-14. PubMed ID: 8284991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of hypertension and hypertension-related left ventricle hypertrophy on right ventricle function.
    Tumuklu MM; Erkorkmaz U; Ocal A
    Echocardiography; 2007 Apr; 24(4):374-84. PubMed ID: 17381646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue velocity echocardiography shows early improvement in diastolic function with irbesartan and atenolol therapy in patients with hypertensive left ventricular hypertrophy. Results form the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA).
    Müller-Brunotte R; Kahan T; Malmqvist K; Ring M; Edner M
    Am J Hypertens; 2006 Sep; 19(9):927-36. PubMed ID: 16942935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated Blood Pressure and Worsening Cardiac Damage During Adolescence.
    Agbaje AO
    J Pediatr; 2023 Jun; 257():113374. PubMed ID: 36870560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concentric left ventricular hypertrophy brings deterioration of systolic longitudinal, circumferential, and radial myocardial deformation in hypertensive patients with preserved left ventricular pump function.
    Mizuguchi Y; Oishi Y; Miyoshi H; Iuchi A; Nagase N; Oki T
    J Cardiol; 2010 Jan; 55(1):23-33. PubMed ID: 20122545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive hypertrophy regression with sustained pressure reduction in hypertension: the Losartan Intervention For Endpoint Reduction study.
    Devereux RB; Palmieri V; Liu JE; Wachtell K; Bella JN; Boman K; Gerdts E; Nieminen MS; Papademetriou V; Dahlöf B
    J Hypertens; 2002 Jul; 20(7):1445-50. PubMed ID: 12131543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ambulatory 24-hour blood pressure monitoring: correlation between blood pressure variability and left ventricular hypertrophy in untreated hypertensive patients.
    Feola M; Boffano GM; Procopio M; Reynaud S; Allemano P; Rizzi G
    G Ital Cardiol; 1998 Jan; 28(1):38-44. PubMed ID: 9493044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired left ventricular synchronicity in hypertensive patients with ventricular hypertrophy.
    Tan HW; Zheng GL; Li L; Wang ZH; Gong HP; Zhang Y; Zhong M; Zhang W
    J Hypertens; 2008 Mar; 26(3):553-9. PubMed ID: 18300868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential prognostic value of ultrasonic characterization (videodensitometry) of myocardial tissue in essential arterial hypertension.
    Di Bello V; Pedrinelli R; Giorgi D; Bertini A; Talini E; Caputo MT; Dell'Omo G; Cioppi A; Moretti L; Paterni M; Giusti C
    Coron Artery Dis; 2000 Oct; 11(7):513-21. PubMed ID: 11023238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal strain of left ventricular basal segments and E/e' ratio differentiate primary cardiac amyloidosis at presentation from hypertensive hypertrophy: an automated function imaging study.
    Schiano-Lomoriello V; Galderisi M; Mele D; Esposito R; Cerciello G; Buonauro A; Della Pepa R; Picardi M; Catalano L; Trimarco B; Pane F
    Echocardiography; 2016 Sep; 33(9):1335-43. PubMed ID: 27277827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart rate variability and left ventricular diastolic function in patients with borderline hypertension with and without left ventricular hypertrophy.
    Martini G; Rabbia F; Gastaldi L; Riva P; Sibona MP; Morra di Cella S; Chiandussi L; Veglio F
    Clin Exp Hypertens; 2001; 23(1-2):77-87. PubMed ID: 11270591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of myocardial diastolic dysfunction on coronary flow reserve in hypertensive patients with left ventricular hypertrophy.
    Galderisi M; Cicala S; De Simone L; Caso P; Petrocelli A; Pietropaolo L; Celentano A; Mininni N; de Divitiis O
    Ital Heart J; 2001 Sep; 2(9):677-84. PubMed ID: 11666096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular and carotid structure in untreated, uncomplicated essential hypertension: results from the Assessment Prognostic Risk Observational Survey (APROS).
    Cuspidi C; Mancia G; Ambrosioni E; Pessina A; Trimarco B; Zanchetti A;
    J Hum Hypertens; 2004 Dec; 18(12):891-6. PubMed ID: 15284833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Four-group classification of left ventricular hypertrophy based on ventricular concentricity and dilatation identifies a low-risk subset of eccentric hypertrophy in hypertensive patients.
    Bang CN; Gerdts E; Aurigemma GP; Boman K; de Simone G; Dahlöf B; Køber L; Wachtell K; Devereux RB
    Circ Cardiovasc Imaging; 2014 May; 7(3):422-9. PubMed ID: 24723582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Losartan reduces left ventricular hypertrophy proportionally to blood pressure reduction in hypertensives, but does not affect diastolic cardiac function.
    Zakynthinos E; Pierutsakos Ch; Konstantinidis K; Zakynthinos S; Papadogiannis D
    Angiology; 2004; 55(6):669-78. PubMed ID: 15547653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.